HC Wainwright & Co. Reiterates Buy on Alto Neuroscience, Maintains $50 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio has reiterated a Buy rating on Alto Neuroscience (NYSE: ANRO) and maintained a price target of $50 for the company's stock.